Create issue ticket

285 Possible Causes for Lack of Developmental Milestones, Mutation in the VPS53 Gene, PaO2 Decreased

  • Neonatal Respiratory Distress Syndrome

    Low PaO2, and if very severe, increased PaCO2 What lab findings are indicative of neonatal respiratory distress syndrome?[quizlet.com] Associated abnormalities are those that can occur in prematurity: germinal matrix hemorrhage, necrotizing enterocolitis, patent ductus arteriosus, delayed developmental milestones[radiopaedia.org] Decreased lung volume (heart appears larger), "ground glass" opacities (hazy diffuse appearance), air bronchograms (normally you cannot see the bronchi out peripherally).[quizlet.com]

    Missing: Mutation in the VPS53 Gene
  • Morbid Obesity

    Linezolid serum concentrations were obtained and vancomycin was reinstituted, after which the patient began to improve (afebrile, improving PaO2/FiO2 ratio, decreasing leukocytosis[ncbi.nlm.nih.gov]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Obesity

    Please log in to edit this article. Edit Synonyms: adipositas, adiposity German : Adipositas, Fettleibigkeit, Fettsucht, Obesitas 1 Definition Obesity is defined as an excessive increase in body fat. The threshold from being overweight to being obese lies at a body mass index (BMI) of 30. Today, obesity is not considered[…][flexikon.doccheck.com]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Atelectasis

    .  Pulse oximetry: (SpO2) (less than 90%) or a (PaO2).  Physical examination: Decreased breath sounds and crackles are heard over the affected area. 13.[slideshare.net] Atelectasis was measured by lung density measurements, in Hounsfield units, with computed tomography scans, decreased PaO2 levels (partial pressure of oxygen dissolved in[ncbi.nlm.nih.gov]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Asthma

    Various conditions such as rhinosinusitis, gastro-oesophageal reflux disease, psychological disturbances, chronic infections and obstructive sleep apnoea are often observed in asthmatic patients and may affect asthma control and outcomes. These comorbidities may change the asthma phenotype, be part of the same[…][ncbi.nlm.nih.gov]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Chronic Obstructive Pulmonary Disease

    There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in chronic obstructive pulmonary disease (COPD). To determine whether or not regular (continuous, intermittent or pulsed) treatment of COPD patients with prophylactic[…][ncbi.nlm.nih.gov]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Preeclampsia

    FIO2 and concomitant decreases in peak inspiratory pressure and PaCO2.67,70 A prospective observational study of ketamine (loading dose 1 mg/kg followed by infusion of 0.75[rc.rcjournal.com] […] asthmaticus, with no serious adverse effects noted.65–69 For mechanically ventilated patients, ketamine administration was associated with increases in dynamic compliance and PaO2[rc.rcjournal.com]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Respiratory Syncytial Virus Infection

    BACKGROUND: To evaluate the role of serum cytokines in the pathogenesis of respiratory syncytial virus (RSV) infection in infants with low birth weight (LBW). METHODS: A prospective observational study was performed, and hospitalized children with lower respiratory tract infection (LRTI) were recruited. Three[…][ncbi.nlm.nih.gov]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Congestive Heart Failure

    […] congestive heart failure (CHF) heart failure caused by impaired pumping capability of the heart that is not keeping up with the metabolic needs of body tissues and organs; it is associated with abnormal retention of water and sodium. It ranges from mild congestion with few symptoms to a life-threatening condition[…][web.archive.org]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene
  • Chronic Bronchitis

    88-92% (PaO2 of 60-70).[clinicaladvisor.com] Therefore, to decrease the likelihood of severe hypercapnea, a safe target oxygen saturation for patients with severe COPD and acute-on-chronic respiratory failure is between[clinicaladvisor.com]

    Missing: Lack of Developmental Milestones Mutation in the VPS53 Gene